Ozempic vs Mounjaro vs Wegovy: Understanding the Cost Question

All three medicines act on GLP-1 pathways to support weight management and blood-glucose regulation, but they are not identical products, and their cost structures differ for several reasons.

Different active substances and indications

Ozempic and Wegovy both contain semaglutide, but they are licensed for different indications: Ozempic is primarily licensed for type 2 diabetes management, while Wegovy is licensed specifically for weight management. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, and is licensed for both type 2 diabetes and, at certain doses, weight management — depending on the country and the prescriber's clinical decision. Because indications differ, funding pathways and out-of-pocket costs can differ significantly even within the same country.

How funding and access affect what you pay

In some countries, one or more of these medicines may be partially or fully covered through national health programmes or insurance schemes — in others, patients pay the full cost privately. Whether a medicine is funded often depends on the specific licensed indication, the patient's clinical profile, and local prescribing criteria. None of this is universal. The right person to explain what applies in your situation is your prescriber or doctor, alongside a registered pharmacist in your country.

Dose and pen format

All three are once-weekly injectables supplied as pre-filled pens, but they come in different dose strengths and pack sizes. Mounjaro is commonly available in strengths from 2.5 mg up to 15 mg; Wegovy ranges from 0.25 mg to 2.4 mg; Ozempic is typically available at 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Because titration schedules differ, the number of pens needed over a given period — and therefore the running cost — is not directly comparable on a pen-for-pen basis.

For a neutral factual overview of how semaglutide and tirzepatide compare as medicines, see our Mounjaro vs Wegovy comparison and our Ozempic vs Wegovy comparison. If you are specifically weighing up the tirzepatide and semaglutide options, the Mounjaro vs Ozempic overview covers the factual differences in a balanced way.

Once you are prescribed one of these medicines, consistency matters — and that is exactly where GLP Trackr is built to help. The app's dose logging feature means every injection is recorded: date, time, and dose strength, so you always know where you are in your schedule and never lose track of a pen mid-course. Dose reminders help you stay on your weekly routine without relying on memory alone.

Beyond logging shots, GLP Trackr's progress tracking — weight charts, daily check-ins, and the week-at-a-glance view — turns your ongoing journey into clear, visual data. That means you can see what is actually moving, discuss it with your prescriber at your next appointment, and feel confident you are making the most of your treatment.

For a broader look at how these medicines compare and what to consider once you are already on one, our main Wegovy vs Mounjaro guide is a good starting point.

Any question about which medicine is right for you, whether to switch, or what your costs might be in your specific situation should go to your prescriber or doctor — they have the full picture of your health and your local options. GLP Trackr is a companion for the journey you are already on, not a substitute for that clinical relationship.

Already prescribed and ready to track every step? GLP Trackr is free to download on the App Store and Google Play — give it a go with a 7-day free trial and see your journey come together in one place.